Discussing Quality-of-Life Issues with a Patient Newly Diagnosed with Prostate Cancer

Published in: Nature Clinical Practice Urology, v. 3, no. 8, Aug, 2006, p. 449-452

Posted on RAND.org on January 01, 2006

by John L. Gore, David F. Penson, Mark Litwin

Read More

Access further information on this document at www.nature.com

This article was published outside of RAND. The full text of the article can be found at the link above.

BACKGROUND: A 66-year-old man with hypertension, hyperlipidemia, and benign prostatic hyperplasia presented for evaluation of an elevated PSA level of 6.2 ng/ml. INVESTIGATIONS: Transrectal ultrasound-guided 12-core prostate needle biopsy. DIAGNOSIS: Clinically localized, clinical stage T1c adenocarcinoma of the prostate. MANAGEMENT: Following a full discussion of the risks and benefits of his treatment options, including quality-of-life sequelae, the patient opted for radical prostatectomy.

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.